Skip to main content
Equibles

Chris Mutz

Analyst

Equibles does not estimate personal net worth.

About Chris Mutz

Chris Mutz has spoken on 2 earnings calls across 1 company, most recently for Ani Pharmaceuticals Inc on August 7, 2026. The companies whose calls Chris Mutz spoke on are classified in the Healthcare sector.

Chris Mutz on recent calls

“In the second quarter, cortrophin grew 43% year-over-year to $117.1 million, in line with our expectations.”
ANI Pharmaceuticals, Inc. Second Quarter 2026 Earnings Call ·
“Starting with slide 9, Cortrofin grew 42% year-over-year to $75.1 million in line with our expectations in the first quarter.”
Ani Pharmaceuticals Inc Q1 FY2026 Earnings Call ·

Company network

Recent activity